best
capabilities
At Advent, we have extensive experience in the generation of high quality research materials such as cell lines…
Adenoviruses are commonly used as efficient genetic vaccine vectors capable of letting the cell express several…
Vaccine manufacturing under cGMP conditions require a complex series of steps to ensure that the final product…
Advent has extensive experience in assay development. Our laboratory is able to develop and validate analytical…
Vaccines and other pharmaceutical drugs must be held to the most stringent quality standards, and an efficient…
Quality Assurance has the scope to guarantee that medicinal products meet the requirements of authorized quality…
Compliance with regulatory guidelines is mandatory for drugs and vaccines meant for human use, but these guidelines…
About Us
We are a world-class contract manufacturing organization focused on the development and manufacturing of investigational lots of adenovirus-based vaccines. We have several years of experience with human and non-human adenoviruses and have successfully released 100% of the lots we have manufactured.
Track Record
Careers
The Jenner Institute signs an agreement with Advent to develop a novel coronavirus vaccine
The Jenner Institute, Oxford University, UK and Advent Srl – an IRBM company, Pomezia,Italy - are continuing their long-standing history…
World Vaccine Congress Washington 2019
Stefania Di Marco, Ph.D., Qualified Person of ADVENT, and Daniel Conlon, IRBM’s VP of Business Development, North America, will be…
World Vaccine Congress Europe 2019
From October 19-21, ADVENT’s Qualified Person, Dr. Stefania di Marco, will attend the World Vaccine Congress Europe 2019 in Barcelona,…